MetaCap

Greenland Mines Ltd. Company Profile

NASDAQ: GRMLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.99+0.08 (+2.75%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Greenland Mines at a glance

Greenland Mines Ltd. (NASDAQ: GRML) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Charlotte, NC. Greenland Mines is led by Dr. Joseph A. Sinkule Pharm.D. and employs about 5 people. The company's shares have traded publicly since 2022.

At a market capitalization of $44.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001907223, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Greenland Mines do?

Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.

Business description based on the company's public filings.

Company information

Legal name
Greenland Mines Ltd.
Ticker
NASDAQ: GRML
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Dr. Joseph A. Sinkule Pharm.D.
Employees
5
Headquarters
1300 South Boulevard, Charlotte, NC, United States
Phone
833 931 6330
IPO year
2022
Market cap
$44.31M
SEC CIK
0001907223
Latest annual report
10-K/A · Aug 14, 2026

Companies similar to Greenland Mines

GRML peer companies
CompanyPrice% ChgMarket capCompare
ELOXEloxx Pharmaceuticals Inc.10.69-1.75%$43.69Mvs GRML
INKTMiNK Therapeutics Inc.8.02-6.85%$41.17Mvs GRML
ELUTElutia Inc. Class A0.9001+11.12%$39.96Mvs GRML
IMAImageneBio Inc.3.920.00%$48.83Mvs GRML
TILInstil Bio Inc.5.23-5.77%$35.47Mvs GRML
AVXLAnavex Life Sciences Corp.0.5915-11.39%$54.83Mvs GRML
CGTXCognition Therapeutics Inc.0.5822-3.06%$55.37Mvs GRML
OKYOOKYO Pharma Limited1.07-7.76%$56.15Mvs GRML

Related